Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IOSP
IOSP logo

IOSP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Innospec Inc (IOSP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
69.700
1 Day change
-1.27%
52 Week Range
102.250
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Innospec Inc (IOSP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators suggest a bearish trend with oversold conditions, but there are no strong positive catalysts or trading signals to justify immediate entry. Financial performance has been weak, with significant YoY declines in revenue, net income, and EPS. Options data and trading trends are neutral, and there is no recent news or influential trading activity to support a bullish case.

Technical Analysis

The stock is in a bearish trend with a negatively expanding MACD histogram (-1.031) and an oversold RSI (17.061). Moving averages are converging, and the stock is trading near its support level (S1: 74.857). The pre-market price is $74.22, slightly below the key support level, indicating potential further downside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
5

Positive Catalysts

  • NULL identified. No recent news or significant trading activity from insiders, hedge funds, or influential figures.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025 with YoY declines in revenue (-2.40%), net income (-167.33%), and EPS (-167.73%). Gross margin also dropped by -4.18%. Technical indicators are bearish, and the stock has a 40% chance of declining in the short term.

Financial Performance

In Q4 2025, revenue dropped to $455.6M (-2.40% YoY), net income fell to $47.4M (-167.33% YoY), and EPS decreased to 1.91 (-167.73% YoY). Gross margin declined to 27.96% (-4.18% YoY), indicating deteriorating profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast IOSP stock price to rise
1 Analyst Rating
Wall Street analysts forecast IOSP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 70.600
sliders
Low
93
Averages
93
High
93
Current: 70.600
sliders
Low
93
Averages
93
High
93
Freedom Capital
initiated
$93
AI Analysis
2025-11-17
Reason
Freedom Capital
Price Target
$93
AI Analysis
2025-11-17
initiated
Reason
Freedom Capital initiated coverage of Innospec with a Buy rating and $93 price target, calling the company an "undervalued" specialty chemicals maker. The firm said it sees potential upside from either new product offerings or opportunistic M&A. Freedom Capital noted that the stock's recent underperformance along with its bottoming earnings "create an attractive risk-reward tradeoff."
Seaport Global
Michael Harrison
Hold
to
Strong Buy
Upgrades
$155
2025-04-21
Reason
Seaport Global
Michael Harrison
Price Target
$155
2025-04-21
Upgrades
Hold
to
Strong Buy
Reason

People Also Watch